In breast cancer, while early studies reported an anti-metastatic role [187], more recent investigations have described that GAL-9 expressed in tumor cells can drive tumor invasiveness and affect chemotherapy outcomes [188]. This evidence concerns the gene LGALS9 and neoplasm.